undefined
EUTM file information

018808927

Asomnia XR


January 24, 2023

Trademark Summary

The trademark application Asomnia XR was filed by Przedsiębiorstwo Farmaceutyczne LEK-AM Sp. z o.o., a corporation established under the laws of the Republic of Poland (the "Applicant"). The application was published for oppositions on March 27, 2023, and it was registered by office on July 4, 2023 without any oppositions.

The application was filed in Polish (English was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical products
    2. Medical preparations
    3. Vitamins and minerals included in this class
    4. Mineral food supplements
    5. Mineral waters for medical purposes
    6. Parapharmaceuticals for medical purposes
    7. Food supplements
    8. Dietetic foods
    9. Dietary substances
    10. Herbal preparations for therapeutic and/or medical purposes
    11. Medicinal herbs
    12. Tea for medical purposes
    13. Biocides for medical purposes
    14. Biological preparations for medical purposes
    15. Biological reagents for medical use
    16. Antibacterial preparations for medical purposes
    17. Vaccines
    18. Serums
    19. Blood derived products
    20. Biotechnological preparations for medical use
    21. Pharmaceutical preparations for skin care
    22. Anti-acne products
    23. Dental preparations and materials
    24. Pharmaceutical lotions
    25. Infant formula
    26. Dressings [medical]
    27. Sanitary preparations for medical purposes
    28. Disinfectants
    29. Veterinary preparations
    30. Diagnostic preparations for medical purposes
    31. Suppositories for medical purposes
    32. Enzyme preparations for medical purposes
    33. Chewing gum for therapeutic use
    34. Beverages for medical purposes
    35. Herbs for medical purposes
    36. Medicinal infusions
    37. Tonics [medicines]
    38. Sulfonamides [medicines]
    39. Herbal medicine
    40. Medicines for human purposes.